Switch Therapeutics is a biotech company that develops RNAi therapies.
Switch Therapeutics has raised $52.0M in total funding. The most recent round was Series A. The last funding was announced in March 2023.
Switch Therapeutics's investors include Insight Partners, Global Brain Corporation, Digitalis Ventures, Upfront Ventures, Freeflow Ventures.
Switch Therapeutics is headquartered in San Francisco, United States.
Switch Therapeutics is a biotech company that develops RNAi therapies.
Switch Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Switch Therapeutics — Funding & Investors." VCBacked, March 14, 2023, https://www.vcbacked.co/company/switch-therapeutics. Accessed July 19, 2026.
VCBacked. (2023). Switch Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/switch-therapeutics
{{cite web |title=Switch Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/switch-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated